Atlas Trials

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Clinical trial NCT03571620 · COMPLETED

Trial details

NCT number
NCT03571620
Sponsor
Qurient Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2018-06-21
Primary completion
2019-11-30
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.